Lee Financial CO Boston Scientific Corp Transaction History

Lee Financial CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $901 - $1,000	-20 Reduced 10.7%	167 $8,000
Q4 2022 Feb 09, 2023	SELL	$39.56 - $47.22 $2,057 - $2,455	-52 Reduced 21.76%	187 $8,000
Q3 2022 Nov 01, 2022	BUY	$36.71 - $109.66 $6,497 - $19,409	177 Added 285.48%	239 $9,000
Q2 2022 Aug 10, 2022	BUY	$35.24 - $47.1 $704 - $942	20 Added 47.62%	62 $3,000
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $1,731 - $1,926	42 New	42 $1,000
Q1 2021 May 13, 2021	SELL	$35.27 - $39.67 $1,763 - $1,983	-50 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $1,657 - $2,098	50 New	50 $2,000
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $1,073 - $1,372	-40 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$25.2 - $28.54 $1,008 - $1,141	40 New	40 $1,000

1,558

1.18B

6.78M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $141B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.